BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, April 18, 2026
Home » Topics » Briefs » Appointments and advancements

Appointments and advancements
Appointments and advancements RSS Feed RSS

Appointments and advancements for Sept. 15, 2020

Sep. 15, 2020
New hires and promotions in the med-tech industry, including: Apiject, Clearpoint Neuro, Element Science, Experity, Microbix, Orthofix, Prolucent, Rapid Micro Biosystems, Satellite Healthcare, Varian.
Read More

Appointments and advancements for Sept. 15, 2020

Sep. 15, 2020
New hires and promotions in the biopharma industry in Asia-Pacific, including: Opthea.
Read More

Appointments and advancements for Sept. 15, 2020

Sep. 15, 2020
New hires and promotions in the biopharma industry, including: Adverum, Aravive, Atea, Aviceda, Haima, Immatics, Kronos, Matinas, Miragen, Nextcure, Partner, Rhythm, Rockwell, Veracyte, Voyager, Vtv, Tizona, Ziopharm.
Read More

Appointments and advancements for Sept. 14, 2020

Sep. 14, 2020
New hires and promotions in the biopharma industry, including: Eloxx, Enosi, Eqrx, Silence, Starton, Synlogic, Vyne.
Read More

Appointments and advancements for Sept. 11, 2020

Sep. 11, 2020
New hires and promotions in the med-tech industry, including: Invitae, Novasignal, United Therapeutics.
Read More

Appointments and advancements for Sept. 11, 2020

Sep. 11, 2020
New hires and promotions in the biopharma industry, including: Corvus, Opthea, Sangamo, Savara, United.
Read More

Appointments and advancements for Sept. 10, 2020

Sep. 10, 2020
New hires and promotions in the med-tech industry, including: Caredx, Cynosure, Everlywell, Welldoc.
Read More

Appointments and advancements for Sept. 10, 2020

Sep. 10, 2020
New hires and promotions in the biopharma industry, including: Aegis, Amarillo, Atlantic Healthcare, GW, Kinnate, Lumen, Neoleukin, Phosplatin, Prevail, Prilenia, Rezolute, Snipr Biome, Spruce, Syros.
Read More

Appointments and advancements for Sept. 9, 2020

Sep. 9, 2020
New hires and promotions in the med-tech industry, including: Discgenics, Entrinsic Biosciences, Medx Health, Sherlock Biosciences, Vitall Intelligence.
Read More

Appointments and advancements for Sept. 9, 2020

Sep. 9, 2020
New hires and promotions in the biopharma industry, including: Adagio, Agios, Allovir, Anika, Atbtherapeutics, Black Diamond, Cognition, DBV, Diffusion, Discgenics, Eli Lilly, Forma, Kymera, Maxcyte, Recode, Starton.
Read More
Previous 1 2 … 274 275 276 277 278 279 280 281 282 … 321 322 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 17, 2026.
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 14, 2026
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • Cancer cell in the cross-hairs

    Selective CBL-B inhibitor with improved safety profile disclosed

    BioWorld Science
    CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing